Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis

To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA. All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were ident...

Full description

Saved in:
Bibliographic Details
Published inSeminars in arthritis and rheumatism Vol. 41; no. 6; pp. 866 - 871
Main Authors Kermani, Tanaz A., Schmidt, Jean, Crowson, Cynthia S., Ytterberg, Steven R., Hunder, Gene G., Matteson, Eric L., Warrington, Kenneth J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2012
Subjects
Online AccessGet full text
ISSN0049-0172
1532-866X
1532-866X
DOI10.1016/j.semarthrit.2011.10.005

Cover

Loading…
Abstract To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA. All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed. We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05). CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis.
AbstractList To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA. All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed. We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05). CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis.
To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA.OBJECTIVESTo evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA.All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed.METHODSAll patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed.We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05).RESULTSWe included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms (P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often (P < 0.05).CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis.CONCLUSIONSCRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis.
Objectives To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of normal ESR and CRP at diagnosis of GCA. Methods All patients undergoing temporal artery biopsy (TAB) between 2000 and 2008 were identified. Only subjects with both ESR and CRP at the time of TAB were included. The medical records of all patients were reviewed. Results We included 764 patients (65% women), mean age 72.7 (±9.27) years, who underwent TAB. Biopsy was consistent with GCA in 177 patients (23%). Elevated CRP and elevated ESR provided a sensitivity of 86.9% and 84.1%, respectively, for a positive TAB. The odds ratio of a concordantly elevated ESR and CRP for positive TAB was 3.06 (95% CI 2.03, 4.62), whereas the odds ratio for concordantly normal ESR and CRP was 0.49 (95% CI 0.29, 0.83). Seven patients (4%) with a positive TAB for GCA had a normal ESR and CRP at diagnosis. Compared with GCA patients with elevated markers of inflammation, a greater proportion of these patients had polymyalgia rheumatica symptoms ( P = 0.008), whereas constitutional symptoms, anemia and thrombocytosis, were observed less often ( P < 0.05). Conclusions CRP is a more sensitive marker than ESR for a positive TAB that is diagnostic of GCA. There may be clinical utility in obtaining both tests in the evaluation of patients with suspected GCA. A small proportion of patients with GCA may have normal inflammatory markers at diagnosis.
Author Schmidt, Jean
Hunder, Gene G.
Kermani, Tanaz A.
Matteson, Eric L.
Warrington, Kenneth J.
Ytterberg, Steven R.
Crowson, Cynthia S.
AuthorAffiliation 2 Department of Internal Medicine, Amiens University Hospital, Amiens, France
3 Division of Biostatistics, Department of Health Sciences Research of, Mayo Clinic, Rochester, USA
1 Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, USA
AuthorAffiliation_xml – name: 3 Division of Biostatistics, Department of Health Sciences Research of, Mayo Clinic, Rochester, USA
– name: 1 Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, USA
– name: 2 Department of Internal Medicine, Amiens University Hospital, Amiens, France
Author_xml – sequence: 1
  givenname: Tanaz A.
  surname: Kermani
  fullname: Kermani, Tanaz A.
  email: kermani.tanaz@mayo.edu
  organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN
– sequence: 2
  givenname: Jean
  surname: Schmidt
  fullname: Schmidt, Jean
  organization: Department of Internal Medicine, Amiens University Hospital, Amiens, France
– sequence: 3
  givenname: Cynthia S.
  surname: Crowson
  fullname: Crowson, Cynthia S.
  organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN
– sequence: 4
  givenname: Steven R.
  surname: Ytterberg
  fullname: Ytterberg, Steven R.
  organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN
– sequence: 5
  givenname: Gene G.
  surname: Hunder
  fullname: Hunder, Gene G.
  organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN
– sequence: 6
  givenname: Eric L.
  surname: Matteson
  fullname: Matteson, Eric L.
  organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN
– sequence: 7
  givenname: Kenneth J.
  surname: Warrington
  fullname: Warrington, Kenneth J.
  organization: Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22119103$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9v1DAQxS1URLeFr4B85JLFdjZxckGUpbRIlUAtlbhZjj3pTsjare1dKd8eR_0HByROlsZPv3nz3hE5cN4BIZSzJWe8fj8sI2x1SJuAaSkY53m8ZKx6QRa8KkXR1PXPA7JgbNUWjEtxSI5iHFgW1ky-IodCcN5yVi7IcJ1wxDRR39PTMGWiN1MCegUWt-CSTugdvdR5pJ2l6-IStEm4B_o9-AToaO8DTRugn1HfOB8xzqgz1C7RNYwjPQkJsk2Mr8nLXo8R3jy8x-T6y-mP9Xlx8e3s6_rkooBVKVPRVlXfdFZy27a2k1obWIkSODArbCd0Y7u6trrnDEwj64aZqhHQSd5xw6qqLI_Jh3vu7a7bgjX5iqBHdRswRzYpr1H9_eNwo278XpUlk03LM-DdAyD4ux3EpLYYTb5FO_C7qHIFlazqlq2y9O2fu56WPAacBZ_uBZAv3iMEFQ2CMzneACYp6zHzZmStBvXcqppbnX9yq88XPUHMiA6NHn_BBHHwu-ByooqrKBRTV3Pvc-2cs2xBzjY__hvwfx5-A15Jxvk
ContentType Journal Article
Copyright 2012 Elsevier Inc.
Elsevier Inc.
Copyright © 2012 Elsevier Inc. All rights reserved.
2011 Elsevier Inc. All rights reserved. 2011
Copyright_xml – notice: 2012 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2012 Elsevier Inc. All rights reserved.
– notice: 2011 Elsevier Inc. All rights reserved. 2011
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.semarthrit.2011.10.005
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-866X
EndPage 871
ExternalDocumentID PMC3307891
22119103
S0049017211003374
1_s2_0_S0049017211003374
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: U54 AR057319
– fundername: NCRR NIH HHS
  grantid: U54 RR019497
– fundername: NCRR NIH HHS
  grantid: U54RR019497
– fundername: NIAMS NIH HHS
  grantid: U54AR057319
– fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS
  grantid: U54 AR057319-09 || AR
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BR6
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OI0
OV-
OZT
P-8
P-9
P2P
PC.
Q38
QTD
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UNMZH
WUQ
XFW
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-e437t-955f8bd71d99db7aace423e1e0d2db2a8db66daf10ec87680c582eb71b1c05533
IEDL.DBID .~1
ISSN 0049-0172
1532-866X
IngestDate Thu Aug 21 13:53:14 EDT 2025
Thu Jul 10 18:12:51 EDT 2025
Mon Jul 21 06:07:30 EDT 2025
Fri Feb 23 02:27:52 EST 2024
Sun Feb 23 10:19:05 EST 2025
Tue Aug 26 17:21:20 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords erythrocyte sedimentation rate
giant cell arteritis
C-reactive protein
temporal artery biopsy
polymyalgia rheumatica
Language English
License Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-e437t-955f8bd71d99db7aace423e1e0d2db2a8db66daf10ec87680c582eb71b1c05533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22119103
PQID 1015756904
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3307891
proquest_miscellaneous_1015756904
pubmed_primary_22119103
elsevier_sciencedirect_doi_10_1016_j_semarthrit_2011_10_005
elsevier_clinicalkeyesjournals_1_s2_0_S0049017211003374
elsevier_clinicalkey_doi_10_1016_j_semarthrit_2011_10_005
PublicationCentury 2000
PublicationDate 2012-06-01
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Seminars in arthritis and rheumatism
PublicationTitleAlternate Semin Arthritis Rheum
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Kermani, Schafer, Crowson, Hunder, Gabriel, Matteson (bib2) 2010; 69
Walvick, Walvick (bib5) 2011; 118
Hayreh, Podhajsky, Raman, Zimmerman (bib6) 1997; 123
Smetana, Shmerling (bib9) 2002; 287
Ellis, Ralston (bib10) 1983; 42
Parikh, Miller, Lee, Savino, Vacarezza, Cornblath (bib8) 2006; 113
Salvarani, Cantini, Hunder (bib1) 2008; 372
Martinez-Taboada, Blanco, Armona, Uriarte, Figueroa, Gonzalez-Gay (bib14) 2000; 19
Kyle, Cawston, Hazleman (bib11) 1989; 48
Cid, Font, Oristrell, de la Sierra, Coll-Vinent, Lopez-Soto (bib15) 1998; 41
Hunder, Bloch, Michel, Stevens, Arend, Calabrese (bib4) 1990; 33
Myklebust, Gran (bib13) 1996; 35
Salvarani, Hunder (bib7) 2001; 45
Crowson, Matteson, Myasoedova, Michet, Ernste, Warrington (bib3) 2011; 63
Pountain, Calvin, Hazleman (bib12) 1994; 33
References_xml – volume: 123
  start-page: 285
  year: 1997
  end-page: 296
  ident: bib6
  article-title: Giant cell arteritis: validity and reliability of various diagnostic criteria
  publication-title: Am J Ophthalmol
– volume: 33
  start-page: 550
  year: 1994
  end-page: 554
  ident: bib12
  article-title: Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis
  publication-title: Br J Rheumatol
– volume: 33
  start-page: 1122
  year: 1990
  end-page: 1128
  ident: bib4
  article-title: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
  publication-title: Arthritis Rheum
– volume: 118
  start-page: 1201
  year: 2011
  end-page: 1204
  ident: bib5
  article-title: Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy
  publication-title: Ophthalmology
– volume: 113
  start-page: 1842
  year: 2006
  end-page: 1845
  ident: bib8
  article-title: Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis
  publication-title: Ophthalmology
– volume: 41
  start-page: 26
  year: 1998
  end-page: 32
  ident: bib15
  article-title: Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis
  publication-title: Arthritis Rheum
– volume: 69
  start-page: 780
  year: 2010
  end-page: 781
  ident: bib2
  article-title: Increase in age at onset of giant cell arteritis: a population-based study
  publication-title: Ann Rheum Dis
– volume: 35
  start-page: 1161
  year: 1996
  end-page: 1168
  ident: bib13
  article-title: A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis
  publication-title: Br J Rheumatol
– volume: 287
  start-page: 92
  year: 2002
  end-page: 101
  ident: bib9
  article-title: Does this patient have temporal arteritis?
  publication-title: JAMA
– volume: 372
  start-page: 234
  year: 2008
  end-page: 245
  ident: bib1
  article-title: Polymyalgia rheumatica and giant-cell arteritis
  publication-title: Lancet
– volume: 48
  start-page: 667
  year: 1989
  end-page: 671
  ident: bib11
  article-title: Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up
  publication-title: Ann Rheum Dis
– volume: 63
  start-page: 633
  year: 2011
  end-page: 639
  ident: bib3
  article-title: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases
  publication-title: Arthritis Rheum
– volume: 42
  start-page: 168
  year: 1983
  end-page: 170
  ident: bib10
  article-title: The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome
  publication-title: Ann Rheum Dis
– volume: 19
  start-page: 73
  year: 2000
  end-page: 75
  ident: bib14
  article-title: Giant cell arteritis with an erythrocyte sedimentation rate lower than 50
  publication-title: Clin Rheumatol
– volume: 45
  start-page: 140
  year: 2001
  end-page: 145
  ident: bib7
  article-title: Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study
  publication-title: Arthritis Rheum
SSID ssj0011607
Score 2.4638333
Snippet To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine...
Objectives To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to...
SourceID pubmedcentral
proquest
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 866
SubjectTerms Aged
Aged, 80 and over
Blood Sedimentation
C-reactive protein
C-Reactive Protein - metabolism
Diagnosis, Differential
erythrocyte sedimentation rate
Female
giant cell arteritis
Giant Cell Arteritis - blood
Giant Cell Arteritis - diagnosis
Giant Cell Arteritis - pathology
Humans
Male
Middle Aged
polymyalgia rheumatica
Polymyalgia Rheumatica - blood
Polymyalgia Rheumatica - diagnosis
Polymyalgia Rheumatica - pathology
Rheumatology
Sensitivity and Specificity
Temporal Arteries - pathology
temporal artery biopsy
Title Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0049017211003374
https://www.clinicalkey.es/playcontent/1-s2.0-S0049017211003374
https://dx.doi.org/10.1016/j.semarthrit.2011.10.005
https://www.ncbi.nlm.nih.gov/pubmed/22119103
https://www.proquest.com/docview/1015756904
https://pubmed.ncbi.nlm.nih.gov/PMC3307891
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwELUQSFUvVb-7pSBX6jXFju0kVk9ogW5bgSralbhZduyIIMgiEg574bd3Jk6WbumhUo-JP2WPx8_ym2dCPlS-kjwPOslklSZScZFYlLtTKITCs9JpjbHDxyfZbC6_nqmzDTIdY2GQVjn4_ujTe289_NkbRnPvuq4xxlfq4QTDhMhRExTV68CmP96taB4cBdTiLTPygvKRzRM5Xm24girP4RgexTx7npda25ce4s4_6ZO_7UdHT8mTAUjS_djXZ2QjNM_Jo-PhqvwFuZh3SHtd0kVFD2-W-BxCuewC_QE5roaAo4aeAtSktvF0mpwG2_s--h2lG-qGApylAA_pQWTj1S1W9RnMqaPTcNk3HXpJpJdkfnT4czpLhocVkiBF3iVaqapwPudea-9ya8sAqCrwwHzqXWoL77LM24qzUIK3LFipijS4nDteMgUA8RXZbBZNeENo4fIK6pKsrIRkriwKy4OsYKSFV0KqCdHjWJox1hO8kwGHbUaC2YW5nweD84ApMA8Tkv-tbGiHZdYabtrUMPPAFCbk06rkmjX9Y7vvx0k3sNjwBsU2YXHbYjGAt5lm0MLraATmOqqCmLTXymMCer1mHqsMKOS9ntLU572gtxAo-s_f_levt8lj-Eojje0d2exubsMOAKbO7fYrYpds7X_5Njv5BTmdGRM
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9wgEEbpRmpzqfpMN31RqVcrYMDY6inaJt002VWVZqXcEBisOGq8Uewc9t93MHjbbXqo1KsxD8EwfGi--UDoY2UrTqUrkoxXacIFZYn2cnfCC6HQrDRF4XOHZ_NsuuBfL8TFFpoMuTCeVhl9f_DpvbeOX_bjbO7f1LXP8eVFvMEQxiR_gLa9OhUfoe2D45PpfB1M8BpqIdDsqUFyIPQEmlfrrqHVS7iJBz3PnuolNo6m-9DzTwblb0fS0RP0OGJJfBCG-xRtueYZejiL0fLn6GrReebrCi8rfHi78i8ilKvO4e_wx3XMOWrwGaBNrBuLJ8mZ0737w9-8ekPdYEC0GBAi_hwIeXXrm_oCFtXhifvRd-16VaQXaHF0eD6ZJvFthcRxJrukEKLKjZXUFoU1UuvSAbBy1BGbWpPq3Joss7qixJXgMHNSijx1RlJDSyIAI75Eo2bZuFcI50ZW0BYnZcU4MWWea-p4BTPNrGBcjFExzKUa0j3BQSnw2WrgmF2pX-ug_Dr4EliHMZJ_q-vauNNaRVWbKqLuWcMYfVrX3DCof-z3w7DoCvabD6Loxi3vWl8NEG5WEOhhNxiBugnCICrt5fIIg1FvmMf6B6_lvVnS1Je9pjdjXvef7v3XqN-jR9Pz2ak6PZ6fvEY7UJIGVtsbNOpu79xbwE-deRf3x0-_yBvE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Utility+of+erythrocyte+sedimentation+rate+and+C-reactive+protein+for+the+diagnosis+of+giant+cell+arteritis&rft.jtitle=Seminars+in+arthritis+and+rheumatism&rft.au=Kermani%2C+Tanaz+A&rft.au=Schmidt%2C+Jean&rft.au=Crowson%2C+Cynthia+S&rft.au=Ytterberg%2C+Steven+R&rft.date=2012-06-01&rft.eissn=1532-866X&rft.volume=41&rft.issue=6&rft.spage=866&rft_id=info:doi/10.1016%2Fj.semarthrit.2011.10.005&rft_id=info%3Apmid%2F22119103&rft.externalDocID=22119103
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00490172%2FS0049017211X00094%2Fcov150h.gif